The pharmaceutical industry’s argument that capping drug prices would compromise drug innovation stands “on very shaky ground.”
The term “vast” sets a high bar.
Former Vice President Joe Biden’s claim during the latest Democratic presidential debate relies on a squishy number, and the context matters.
Surgeon General Jerome Adams said the drug has a “unique impact” on the developing brain — technically true, but neglecting a vital comparison to other drugs, as well as shortcomings in the existing research.
Big picture remains hazy, but these numbers add up.
Polling supports Buttigieg’s claim.
Warren’s claim on health insurance and bankruptcy is narrow enough to hold up.
It comes down to questionable methodology.
The topic, which polls show is top of mind among voters, kept returning throughout the fourth debate of Democratic presidential candidates.
The president’s outline of key health policy concerns touched on a variety of hot-button issues from drug prices to immigration.
With nearly 72% of U.S. adults considered overweight or obese, the pressing question is: Is it possible to be overweight and healthy at the same time? The science falls short.
It turns out the health care plans put forth by the campaigns of former Vice President Joe Biden and former Cabinet secretary Julián Castro are not that different.
Sen Bernie Sanders’ statement during Thursday night’s Democratic debate serves up interesting data, with a side of misrepresentation.
When it came to health care plans, there were big ideas and big numbers, even though fewer candidates were on the stage.
A case of questionable logic.
The Wednesday night event marked the second night in a row for Democratic presidential hopefuls to stake claims on how to fix the health care system.
Candidates used their varying views on how to achieve universal coverage — whether through Medicare for All or more incremental steps — as a means to differentiate themselves from the field.
The health policy landscape is very different than it was when Barack Obama made this pledge as part of his pitch for the Affordable Care Act. But the words still might be risky for Democratic presidential primary hopeful Joe Biden.
The drug industry has the biggest lobbying war chest.
The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president’s promise to curb high drug prices.